Vitaly Ablamunits, M.D., Ph.D.


Vitaly Ablamunits, M.D., Ph.D.


CONTACT INFORMATION

404 West 114th street,
Room S&R 8916,
New York, NY, 10025

Phones: 917-209-5429 (mobile)
212-523-1632 (office)
E-mail: ablamunits@excite.com



EDUCATION

1975-1981Saratov State Medical Institute MD studies, MD degree Saratov, Russia "With high honors" in internal medicine
1993-1999The Weizmann Institute of Science, PhD studies, PhD degree Rehovot, Israel in immunology
Thesis: "Cytokines in Type 1 diabetes mellitus" Supervisor: Prof. Irun R. Cohen

MEMBERSHIP IN PROFESSIONAL ORGANIZATION

PUBLICATIONS

  1. Klebanov S, Astle CM, De Simon O, Ablamunits V, Harrison DE. Transplantation of normal adipose tissue to female ob/ob mice protects them from obesity, normalizes their insulin sensitivity and restores fertility. J Endocrinol 2005, 186: 203
  2. Ablamunits V, Bridgett M, Duffy T, Haag F, Nissen M, Koch-Nolte F, Leiter E H. Changing patterns of cell surface mono (ADP-ribosyl) transferase antigen ART2.2 on resting versus cytopatically-activated T cells in NOD/Lt mice. Diabetologia 2001, 44: 848
  3. Ablamunits V, Quintana F, Reshef T, Elias D, Cohen IR. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway. J Autoimmun. 1999,13:383
  4. Koch-Nolte F, Duffy T, Nissen M, Kahl S, Killeen N, Ablamunits V, Haag F, Leiter EH. A new monoclonal antibody detects a developmentally regulated mouse ecto-ADP-ribosyltransferase on T cells: subset distribution, inbred strain variation, and modulation upon T cell activation. J Immunol. 1999, 163:6014
  5. Tikochinski Y, Elias D, Steeg C, Marcus H, Kantorowitz M, Reshef T, Ablamunits V, Cohen IR, Friedmann A. A shared TCR CDR3 sequence in NOD mouse autoimmune diabetes. Int Immunol 1999, 11:951
  6. Arava Y, Adamsky K, Ezerzer C, Ablamunits V, Walker MD. Specific gene expression in pancreatic beta-cells: cloning and characterization of differentially expressed genes. Diabetes 1999, 48 :552
  7. Ablamunits V, Elias D, Cohen IR. The pathogenicity of islet-infiltrating lymphocytes in the non-obese diabetic (NOD) mouse. Clin Exp Immunol 1999, 115:260
  8. Ablamunits V, Elias D, Reshef T, Cohen IR. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment. J Autoimmun 1998, 11:73
  9. Elias D, Meilin A, Ablamunits V, Birk OS, Carmi P, Konen-Waisman S, Cohen IR. Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various beta-cell antigens. Diabetes. 1997 May;46(5):758
  10. Elias D, Marcus H, Reshef T, Ablamunits V, Cohen IR. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein. Eur J Immunol. 1995, 25:2851
  11. Ablamunits V, Baranova F, Mandrup-Poulsen T, Nerup J. In vitro inhibition of insulin release by blood mononuclear cells from insulin-dependent diabetic and healthy subjects: synergistic action of IL-1 and TNF. Cell Transplant. 1994, 3:55


Back to Staff Page || Back to Main Page